Challenges and Solutions in Conducting Biosimilar Trials Webinar

March 6, 2013 9:51 AM

Xtalks presents a live webinar on conducting successful biosimilar trials. Xtalks is offering two live broadcast on Tuesday March 19, 2013 at 4pm KST (South Korea) and 11am EST (N. America).

The expiration of patents and other intellectual property rights for originator biologics over the next decade opens up opportunities for biosimilars to enter the market and increase competition. Despite the challenges associated with biosimilar drug development, many drug manufacturers are entering the race to develop biosimilars — especially for blockbuster mAbs. With increased clinical trial activity through Phase III, the ability to recruit patients into these important studies becomes a key stepping stone to biosimilar commercial success.

The speaker will be Rodeina Challand, Executive Director of Biosimilars Development at PRA and a Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtks.in/xto565-event

 

Would you like to post an event on Biosimilar News?

Comments are closed

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!